Investment Thesis
HeartCore faces critical financial distress with zero revenue growth, operating losses exceeding 120% of revenue, and negative cash flow burning $2.7M annually. The company has only ~4 months of cash runway at current burn rates with a fundamentally broken business model evidenced by a 5.9% gross margin. Absent immediate capital infusion or dramatic operational turnaround, liquidity crisis is imminent.
Strengths
- Low debt burden (0.07x debt/equity ratio) limits obligations
- Modest net income improvement YoY suggests some operational efforts
- Positive stockholders equity of $6.9M provides liquidation value cushion
Risks
- Catastrophic cash burn of $2.7M annually with only $774K cash on hand
- Zero revenue growth combined with massive operating losses (-123.7% margin)
- Critically low gross margin (5.9%) indicates structural business model failure
- Negative interest coverage ratio indicates inability to service existing debt from operations
- Interest expense and operational losses consuming all revenue; no path to profitability without major changes
Key Metrics to Watch
- Operating cash flow and monthly burn rate (approaching insolvency if not positive soon)
- Revenue growth acceleration and gross margin improvement (fundamental viability test)
- Cash balance and days of runway remaining (liquidity crisis timeline)
Financial Metrics
Revenue
1.2M
Net Income
-1.9M
EPS (Diluted)
$-1.49
Free Cash Flow
-2.7M
Total Assets
11.8M
Cash
774.0K
Profitability Ratios
Gross Margin
5.9%
Operating Margin
-123.7%
Net Margin
-150.2%
ROE
-27.2%
ROA
-15.9%
FCF Margin
-214.8%
Balance Sheet & Liquidity
Current Ratio
1.17x
Quick Ratio
1.17x
Debt/Equity
0.07x
Debt/Assets
55.3%
Interest Coverage
-1,082.57x
Long-term Debt
486.6K
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-23T08:30:19.763886 |
Data as of: 2026-03-31 |
Powered by Claude AI